Marco Cid, Director General of Investigacion Biomedica, shares how he successfully launched an innovative clinical research center (CRC) despite a challenging regulatory environment. He speaks about the inspiration behind his business model, the necessity of building a strong rapport with authoritative entities in the market, as well as fostering a spirit of collaboration in cultivating the growth of the landscape to entice further investment in this sphere. Mr. Cid, what was your primary inspiration for founding Investigacion Biomedica and what were the key gaps in the market that needed to be catered to with this business model?
"Current research sites display a clear lack of quality, especially when put in contrast with the international standards held by large pharmaceutical companies. Catering to improving this status quo is the gap that we identified in the market."